Jones Trading Initiates Coverage On ProQR Therapeutics with Buy Rating, Announces Price Target of $11
Benzinga Newsdesk 1 year ago
NewsPrice TargetInitiationAnalyst Ratings
Jones Trading analyst Catherine Novack initiates coverage on ProQR Therapeutics (NASDAQ:PRQR) with a Buy rating and announces Price Target of $11.
Jones Trading analyst Catherine Novack initiates coverage on ProQR Therapeutics (NASDAQ:PRQR) with a Buy rating and announces Price Target of $11.